Some FDA staff considering quitting due to Trump’s RTO policy

Regulatory News

Regulatory NewsFerdous Al-Faruque

Biologics/ biosimilars/ vaccinesGovernment/legislationMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)